Inventor profile of:

Django Sussman

City:

Bothell, Washington

Country:

United States

Published Applications:

18

Last publication date:

2024-07-25

Top Assignees for applications by Django Sussman

The entities that hold a legal rights for patent applications filed by inventor Sussman Django:

Recent patent applications by Sussman Django

Django Sussman from Bothell, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-07-25
US20240247059A1
Chemistry; metallurgy

HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

#2 | 2023-02-23
US20230055475A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MAKING ANTIBODIES AND ANTIBODY DERIVATIVES WITH REDUCED CORE FUCOSYLATION

#3 | 2022-06-09
US20220175947A1
Human necessities

Cysteine mutated antibodies for conjugation

#4 | 2021-02-18
US20210047404A1
Chemistry; metallurgy

CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER

#5 | 2020-05-28
US20200165335A1
Chemistry; metallurgy

HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

#6 | 2019-12-19
US20190381171A1
Human necessities

CO-USE OF ANTI-BCMA ANTIBODY AND ANTIBODY-COUPLED T CELL RECEPTOR (ACTR) IN CANCER THERAPY AND B CELL DISORDERS

#7 | 2019-09-12
US20190276796A1
Chemistry; metallurgy

Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation

#8 | 2018-06-07
US20180155677A1
Chemistry; metallurgy

Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation

#9 | 2018-03-22
US20180079810A1
Chemistry; metallurgy

Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer

#10 | 2017-07-20
US20170204180A1
Chemistry; metallurgy

CD33 antibodies and use of same to treat cancer

#11 | 2016-06-30
US20160185858A1
Chemistry; metallurgy

Humanized antibodies to LIV-1 and use of same to treat cancer

#12 | 2015-11-26
US20150337259A1
Chemistry; metallurgy

Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation

#13 | 2015-05-28
US20150147316A1
Chemistry; metallurgy

CD33 antibodies and use of same to treat cancer

#14 | 2014-01-30
US20140031536A1
Chemistry; metallurgy

Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation

#15 | 2013-11-21
US20130309223A1
Chemistry; metallurgy

CD33 Antibodies And Use Of Same To Treat Cancer

#16 | 2013-10-03
US20130259860A1
Chemistry; metallurgy

Humanized antibodies to LIV-1 and use of same to treat cancer

#17 | 2012-07-19
US20120183997A1
Chemistry; metallurgy

Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation

#18 | 2009-12-24
US20090317869A1
Chemistry; metallurgy

Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation

InventorID:

466961 ⎘